Department of Commerce organizes Chintan Shivir on strengthening India’s Medical Devices export ecosystem

1. At a Glance

Chintan Shivir held on 14 March 2026 at Vanijya Bhawan, New Delhi by Department of Commerce, in collaboration with Department of Pharmaceuticals (DoP) and Export Promotion Council for Medical Devices (EPCMD) [S1][S2].
Anchored on the "30@2030" vision — scaling India's MedTech market to USD 30 billion by 2030 [S2].
Relevant for GS-III (economy, manufacturing, exports, science/tech) — links PLI, National Medical Devices Policy 2023, and India's healthcare export competitiveness [S3][S4].

2. Why in the News

Department of Commerce convened a Chintan Shivir on "Strengthening India's Medical Devices Export Ecosystem" with 150+ participants from government, regulators, industry and EPCMD [S2].
Secretary, Department of Commerce, Shri Rajesh Agarwal announced medical device exports crossed USD 4 billion in FY25 and reaffirmed the 30@2030 market-size target [S2].

3. Background & Evolution

2017: Ministry of Health & Family Welfare notified Medical Devices Rules, 2017 under the Drugs and Cosmetics Act, 1940 [S5].
2020: Launch of PLI Scheme for Medical Devices with outlay ₹3,420 crore, production tenure FY 2022-23 to FY 2026-27 [S3].
2023: Cabinet approved the National Medical Devices Policy, 2023 targeting growth of the sector from ~USD 11 bn to USD 50 bn by 2030 [S3].
2024: CDSCO became Affiliate Member of the International Medical Device Regulators Forum (IMDRF) [S6].
FY25: Exports reached USD 4.1 billion, up from USD 2.5 bn in FY21; shipments to 187 countries [S5].
14 March 2026: Chintan Shivir at Vanijya Bhawan [S2].

4. Core Static Facts

Theme: "Achieving 30@2030 – USD 30 Billion Market Size by 2030" [S2].
Organisers: Department of Commerce + Department of Pharmaceuticals + EPCMD [S2].
Venue: Vanijya Bhawan, New Delhi (inaugurated by PM Modi on 23 June 2022 alongside NIRYAT portal) [S2].
Nodal Ministry for MedTech regulation: Ministry of Health & Family Welfare via CDSCO [S5][S6].
Nodal Ministry for manufacturing promotion: Department of Pharmaceuticals (Ministry of Chemicals & Fertilizers) [S3].
Nodal Ministry for export promotion: Department of Commerce (Ministry of Commerce & Industry) [S2].
Statutory base: Drugs and Cosmetics Act, 1940; Medical Devices Rules, 2017 [S5].
PLI outlay: ₹3,420 crore; 19 greenfield projects commissioned; 44 products indigenised (LINAC, MRI, CT, Mammogram, C-Arm, Ultrasound) [S3].
Cumulative PLI sales up to Sept 2024: ₹8,039.63 crore (exports ₹3,844.01 crore) [S3].
FY25 exports: USD 4.1 bn to 187 countries [S5].

5. Multi-Dimensional Analysis

Economic - MedTech market currently ~USD 14 bn; targeted USD 30 bn by 2030 (≈2x growth) [S3]. - PLI-driven import substitution in high-end imaging equipment (MRI/CT/LINAC) addresses ~80% historical import dependence [S3].

Scientific / Technological - CDSCO's IMDRF affiliate membership signals harmonisation with global regulators (US FDA, EU, Japan PMDA, Health Canada) [S6]. - Push for indigenous high-end devices reduces tech-import reliance [S3].

Strategic / Geopolitical - Exports diversified across 187 countries — reduces single-market risk; aligns with India's pitch as the "Pharmacy of the World" extending to MedTech [S5].

Administrative / Governance - Multi-ministry coordination: Commerce (export), DoP (manufacturing), MoHFW/CDSCO (regulation) — federal coordination challenge [S2][S5]. - EPCMD serves as the sector-specific Export Promotion Council under DGFT framework [S2].

Legal / Regulatory - Medical Devices Rules, 2017 progressively expanded notified categories; risk-based classification (Class A/B/C/D) [S5].

6. Recent Developments (last 12-18 months)

14 Mar 2026: Chintan Shivir on MedTech exports at Vanijya Bhawan [S2].
FY25: Exports of USD 4.1 bn; spread across 187 countries [S5].
2024: CDSCO becomes IMDRF Affiliate Member [S6].
2024: 27 Greenfield Bulk Drug Park projects and 13 Greenfield Medical Devices Manufacturing Plants under PLI inaugurated by then-Minister Mandaviya [S7].
Up to Sept 2024: PLI cumulative sales ₹8,039.63 cr; exports ₹3,844.01 cr [S3].

7. Prelims Hooks

Chintan Shivir on MedTech exports organised by Department of Commerce, not Department of Pharmaceuticals [S2].
Theme: "30@2030" — USD 30 bn market by 2030 [S2].
Held at Vanijya Bhawan, New Delhi (which also houses the NIRYAT portal launched 23 June 2022) [S2].
Collaborating body: Export Promotion Council for Medical Devices (EPCMD) [S2].
India's MedTech exports in FY25: USD 4 billion+ / USD 4.1 bn [S2][S5].
Exports to 187 countries in FY25 [S5].
PLI Scheme for Medical Devices outlay: ₹3,420 crore (2020) [S3].
PLI tenure: FY 2022-23 to FY 2026-27 [S3].
19 greenfield projects commissioned; 44 high-end products indigenised under PLI [S3].
Indigenously produced under PLI: LINAC, MRI, CT, Mammogram, C-Arm, Ultrasound [S3].
Regulatory body: CDSCO under MoHFW, governed by Drugs and Cosmetics Act, 1940 + Medical Devices Rules, 2017 [S5].
CDSCO became IMDRF Affiliate Member in 2024 [S6].
National Medical Devices Policy approved by Cabinet in 2023 [S3].
Secretary, Department of Commerce (Mar 2026): Shri Rajesh Agarwal [S2].

8. Mains Relevance

GS-III — Indian Economy: growth, employment; Effects of liberalisation on the economy; Science & Technology – indigenisation.
GS-II — Government policies & interventions for development in various sectors.
Possible question stems: 1. "Discuss how the PLI scheme and the 30@2030 vision can transform India into a global MedTech hub. What are the structural bottlenecks?" 2. "India's medical devices sector remains import-dependent despite policy push. Critically analyse." 3. "Examine the role of harmonised regulation (CDSCO–IMDRF) in scaling India's MedTech exports."

9. Related Topics to Study Next

PLI Schemes (14 sectors) — flagship manufacturing push; MedTech is one sector [S3].
National Medical Devices Policy, 2023 — overarching framework [S3].
Drugs and Cosmetics Act, 1940 & Medical Devices Rules, 2017 — statutory backbone [S5].
CDSCO & IMDRF membership — regulatory harmonisation [S6].
NIRYAT portal & Vanijya Bhawan — export information architecture [S2].
Scheme for Strengthening the Medical Device Industry (DoP) — supporting scheme [S7].
Bulk Drug Parks scheme — sister initiative reducing API import dependence [S7].
Pharma Exports & Pharmexcil — comparison with MedTech export ecosystem [S2].

10. Common Errors / Trap Areas

Nodal ministry confusion: Chintan Shivir was by Department of Commerce (Min. of Commerce & Industry); not by Department of Pharmaceuticals or MoHFW [S2].
Regulator vs Promoter: CDSCO regulates (MoHFW); DoP promotes manufacturing; DGFT/Commerce promotes exports — don't conflate [S5][S3].
Target figure mix-up: 30@2030 refers to USD 30 bn market size, not exports — exports were USD 4 bn in FY25 [S2].
PLI outlay is ₹3,420 crore (Medical Devices PLI), distinct from the ₹15,000 cr Pharma PLI [S3].
Medical Devices Rules are of 2017 (not 2020); under the 1940 Act, not a standalone Medical Devices Act [S5].

11. Sources

[S1] Press Release — Department of Commerce organizes Chintan Shivir on strengthening India's Medical Devices export ecosystem — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2240258 — (tier: 1)
[S2] PIB — Chintan Shivir on Medical Devices Export Ecosystem (Hindi mirror) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2240258&reg=3&lang=1 — (tier: 1)
[S3] PIB — Progress and implementation of the PLI scheme for medical devices — https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2204598 — (tier: 1)
[S4] PIB — Cabinet approves the Policy for the Medical Devices Sector — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1919984 — (tier: 1)
[S5] PIB — Import and Export of Medical Devices — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2239563 — (tier: 1)
[S6] PIB — CDSCO becomes Affiliate Member of IMDRF — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2061397 — (tier: 1)
[S7] PIB — Mandaviya Inaugurates 27 Greenfield Bulk Drug Parks and 13 Greenfield Medical Device Plants under PLI — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2010924 — (tier: 1)